FulcrumTx

@FulcrumTx

Clinical-stage biopharma focused on improving the lives of patients with genetic diseases in areas of high unmet need. Guidelines:

Vrijeme pridruživanja: listopad 2015.

Tweetovi

Blokirali ste korisnika/cu @FulcrumTx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FulcrumTx

  1. prije 11 sati

    is February 29. This year, community leaders and our team members shared how they hope to reframe rare for the future. Stay tuned this month for their answers. How do YOU hope to ?

    Poništi
  2. 3. velj

    Our SVP and Head of Clinical Development, Dr. Diego Cadavid recently discussed the genetic factors behind and the progression of its symptoms in an interview with See the full interview here:

    Poništi
  3. 31. sij

    the global incidence of is estimated to be approximately 300,000 births each year.

    Poništi
  4. 29. sij

    We are excited to announce that losmapimod has been granted Orphan Drug Designation in by the FDA and we have expanded our patent portfolio. Learn more about this news:

    Poništi
  5. 29. sij

    Want to stay connected to the latest happenings at Fulcrum? Follow us on !

    Poništi
  6. 24. sij

    patient champion Chris Stenmon is featured in the this week as a Newsmaker for his work to raise awareness for the disease. Read more about him:

    Poništi
  7. 24. sij

    While disease is most prevalent in Africa and the Middle East, an approximated 234,000 individuals in the U.S. and Europe are also affected.

    Poništi
  8. 21. sij

    We're looking for highly motivated and passionate new team members! Learn more about our open positions here:

    Poništi
  9. 17. sij

    Did you know that it's ? If you are of African ancestry, consider donating your blood this month to those with - they need blood from those of similar ancestry in order to stay healthy!

    Poništi
  10. 16. sij

    Sickle cell disease is caused by a mutation in the HBB gene that gives rise to mutated beta-subunits. Learn how we're working to address the root cause of this disease:

    Poništi
  11. 13. sij

    The Fulcrum team was excited to help raise awareness of at Eliot Intermediate School this fall. Learn more about our visit in the 's article here:

    Poništi
  12. 13. sij

    We're excited to be attending this year's Healthcare Conference in San Francisco! We're eager to meet with some of the biggest leaders in the healthcare industry.

    Poništi
  13. 9. sij

    Sickle cell disease is reported to shorten patient life expectancy by approximately 20 to 30 years. We're working to change that. Learn about our focus on

    Poništi
  14. 8. sij

    We're proud to announce that our clinical development program has been recognized in 's list of the Top 10 Muscular Dystrophy Stories of 2019. See the whole list here:

    Poništi
  15. 7. sij

    Teonna has used her diagnosis to inspire her work as an advocate for the community. Learn more about her story on our website.

    Poništi
  16. 6. sij

    We’re pleased to announce that Katina Dorton has been appointed to our board where she will also serve as chair of the audit committee. Learn more about her experience and what this means for Fulcrum here:

    Poništi
  17. 3. sij

    to our holiday volunteering event at East End House. Our team members were extremely generous with their donations of gifts and time to help those in need. We had a blast!

    Poništi
  18. 1. sij

    Happy New Year from the Fulcrum family! We are excited for the progress that 2020 has in store! Check out our pipeline for a preview of what's in store.

    Poništi
  19. 30. pro 2019.

    We’re excited to announce a research collaboration with to identify small molecules designed to modulate genetic pathways associated with an indication in . Learn more about our partnership here:

    Poništi
  20. 25. pro 2019.

    from the Fulcrum family to yours!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·